# Ambroxol Spray Sore Throat Study

> **NCT01361802** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 494 (actual)

## Conditions studied

- Pharyngitis
- Pain

## Interventions

- **DRUG:** Ambroxol Spray
- **DRUG:** Ambroxol Spray
- **DRUG:** Ambroxol Spray
- **DRUG:** Placebo Spray

## Key facts

- **NCT ID:** NCT01361802
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-08
- **Final completion:** —
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361802, "Ambroxol Spray Sore Throat Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01361802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*